Ranked #2,512 of 8,699 institutional investors
PFM Health Sciences, LP
San Francisco, CA
$910M
US stock portfolio at live prices · today −$11.1M (−1.21%)
Market closed. Prices as of Nov 20, 9:11 AM ET
- Value at quarter end (Q3 2026)
- $936M
- Change from Q2 2026
- −$215.5M (−18.71%)
- Positions
- 73 · 20 new, 35 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $7.8M of stock, put options on $58.5M. $101M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesUTHR 4.25%LLY 3.72%THC 3.69%NBIX 3.52%AXSM 3.31%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 69,243 | $38.7M | 4.25% | Added +39% |
| LLY Eli Lilly and Company | 25,076 | $33.9M | 3.72% | Reduced −36% |
| THC Tenet Healthcare Corporation | 127,294 | $33.6M | 3.69% | Added +1% |
| NBIX Neurocrine Biosciences, Inc. | 204,336 | $32.0M | 3.52% | Reduced −4% |
| AXSM Axsome Therapeutics, Inc. | 222,102 | $30.1M | 3.31% | Added +1% |
| BBIO BridgeBio Pharma, Inc. | 365,570 | $28.6M | 3.14% | Added +44% |
| INBX Inhibrx Biosciences, Inc. | 320,331 | $23.8M | 2.62% | Added +4% |
| SPY State Street SPDR S&P 500 ETF Trust | 32,421 | $23.2M | 2.55% | New |
| TMO Thermo Fisher Scientific Inc. | 31,985 | $22.0M | 2.42% | Added +12% |
| SUPN Supernus, Inc. | 741,864 | $21.0M | 2.31% | Added +85% |
| WAT Waters Corporation | 43,916 | $20.0M | 2.20% | Reduced −27% |
| HUM Humana Inc. | 51,078 | $19.4M | 2.13% | Reduced −46% |
| GKOS Glaukos Corporation | 80,322 | $19.1M | 2.10% | New |
| TFX Teleflex Incorporated | 116,072 | $19.0M | 2.08% | Added +46% |
| ABT Abbott Laboratories | 176,434 | $18.3M | 2.01% | Added +115% |
| AMRX Amneal Pharmaceuticals, Inc. | 822,891 | $17.6M | 1.93% | Added +71% |
| UNH UnitedHealth Group Incorporated | 49,666 | $16.4M | 1.80% | Reduced −44% |
| RVMD Revolution Medicines, Inc. | 102,109 | $16.3M | 1.79% | Reduced −29% |
| GMAB Genmab A/S | 313,679 | $16.1M | 1.77% | New |
| EW Edwards Lifesciences Corporation | 151,822 | $15.8M | 1.73% | Reduced −39% |
| ZBH Zimmer Biomet Holdings, Inc. | 155,425 | $15.8M | 1.73% | New |
| CNMD CONMED Corporation | 324,246 | $15.0M | 1.65% | New |
| CYTK Cytokinetics, Incorporated | 258,822 | $13.3M | 1.46% | Added +35% |
| OSCR Oscar Health, Inc. | 499,837 | $13.1M | 1.44% | Reduced −4% |
| EXEL Exelixis, Inc. | 188,789 | $12.4M | 1.37% | New |
| TAK Takeda Pharmaceutical Company Limited | 567,101 | $12.1M | 1.33% | Added +28% |
| MDGL Madrigal Pharmaceuticals, Inc. | 28,876 | $11.5M | 1.26% | Reduced −1% |
| PRAX Praxis Precision Medicines, Inc. | 36,484 | $11.3M | 1.25% | Reduced −5% |
| CNC Centene Corporation | 169,555 | $11.1M | 1.22% | Reduced −32% |
| KOD Kodiak Sciences Inc. | 109,547 | $10.7M | 1.18% | Reduced −43% |
| VEEV Veeva Systems Inc. | 39,679 | $10.4M | 1.15% | New |
| DHR Danaher Corporation | 45,663 | $10.4M | 1.14% | New |
| DFTX Definium Therapeutics, Inc. | 335,101 | $9.9M | 1.09% | Added +35% |
| IRTC iRhythm Holdings, Inc. | 96,593 | $9.1M | 1.00% | Added +48% |
| ELAN Elanco Animal Health Incorporated | 344,946 | $9.1M | 1.00% | Added +100% |
| BLTE Belite Bio, Inc | 55,078 | $8.3M | 0.91% | Added +58% |
| BTSG BrightSpring Health Services, Inc. | 127,603 | $8.2M | 0.90% | Reduced −10% |
| CRL Charles River Laboratories International, Inc. | 24,347 | $8.0M | 0.88% | Added +30% |
| IART Integra LifeSciences Holdings Corporation | 578,981 | $7.8M | 0.86% | Added +66% |
| BIO Bio-Rad Laboratories, Inc. | 20,283 | $7.5M | 0.82% | Added +45% |
| AMLX Amylyx Pharmaceuticals, Inc. | 282,434 | $7.4M | 0.81% | Added +97% |
| EPRX Eupraxia Pharmaceuticals Inc. | 1,127,921 | $6.9M | 0.76% | Reduced −7% |
| GEHC GE HealthCare Technologies Inc. | 83,574 | $6.8M | 0.75% | New |
| DOCS Doximity, Inc. | 226,163 | $6.7M | 0.74% | New |
| CLDX Celldex Therapeutics, Inc. | 235,815 | $6.6M | 0.72% | Reduced −31% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 150,032 | $6.5M | 0.72% | Added +14% |
| RYTM Rhythm Pharmaceuticals, Inc. | 55,987 | $6.5M | 0.72% | Reduced −45% |
| WST West Pharmaceutical Services, Inc. | 16,309 | $6.5M | 0.71% | Reduced −21% |
| HNGE Hinge Health, Inc. | 58,635 | $6.3M | 0.70% | Reduced −29% |
| GH Guardant Health, Inc. | 42,411 | $6.2M | 0.68% | Added +16% |
| OMCL Omnicell, Inc. | 168,443 | $5.6M | 0.61% | Added +243% |
| DNTH Dianthus Therapeutics, Inc. | 61,299 | $5.2M | 0.57% | Reduced −49% |
| IONS Ionis Pharmaceuticals, Inc. | 190,905 | $5.2M | 0.57% | New |
| VKTX Viking Therapeutics, Inc. | 188,372 | $4.9M | 0.53% | Reduced −26% |
| HCA HCA Healthcare, Inc. | 9,692 | $4.5M | 0.49% | Added +17% |
| VERA Vera Therapeutics, Inc. | 143,973 | $3.9M | 0.42% | Reduced −36% |
| DXCM DexCom, Inc. | 46,092 | $3.7M | 0.41% | New |
| MMED MiniMed Group, Inc. | 204,663 | $3.3M | 0.37% | New |
| IQV IQVIA Holdings Inc. | 10,710 | $2.7M | 0.29% | New |
| OMDA Omada Health, Inc. | 210,296 | $2.6M | 0.29% | Added +84% |
| CELC Celcuity Inc. | 45,361 | $2.6M | 0.28% | Reduced −13% |
| QQQ Invesco QQQ Trust | 3,713 | $2.4M | 0.26% | New |
| FRNM Freenome, Inc. | 231,790 | $2.3M | 0.25% | New |
| ABVX ABIVAX Société Anonyme | 23,906 | $1.9M | 0.21% | Reduced −45% |
| ERAS Erasca, Inc. | 135,068 | $1.9M | 0.21% | Added +1% |
| SVRA Savara Inc. | 345,824 | $1.8M | 0.20% | New |
| OM Outset Medical, Inc. | 582,122 | $1.7M | 0.19% | Unchanged |
| TWST Twist Bioscience Corporation | 15,026 | $1.7M | 0.18% | New |
| TXG 10x Genomics, Inc. | 20,376 | $1.2M | 0.13% | New |
| GPCR Structure Therapeutics Inc. | 66,404 | $1.1M | 0.12% | Reduced −27% |
| SOXX iShares Semiconductor ETF | 7,350 | $1.0M | 0.11% | New |
| CGEM Cullinan Therapeutics, Inc. | 104,715 | $950K | 0.10% | Reduced −46% |
| CRBU Caribou Biosciences, Inc. | 354,687 | $110K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| MTD Mettler-Toledo International Inc. | 13,344 | $22.8M |
| PEN Penumbra, Inc. | 60,221 | $19.3M |
| ACHC Acadia Healthcare Company, Inc. | 524,934 | $18.1M |
| SYK Stryker Corporation | 56,637 | $17.7M |
| MRK Merck & Co., Inc. | 127,118 | $16.9M |
| MMSI Merit Medical Systems, Inc. | 197,038 | $16.6M |
| ORKA Oruka Therapeutics, Inc. | 158,825 | $15.5M |
| GILD Gilead Sciences, Inc. | 90,858 | $15.1M |
| LNTH Lantheus Holdings, Inc. | 146,403 | $14.9M |
| COO The Cooper Companies, Inc. | 220,890 | $13.3M |
| HSIC Henry Schein, Inc. | 134,423 | $11.4M |
| CVS CVS Health Corporation | 137,457 | $11.0M |
| CGON CG Oncology, Inc. | 128,286 | $10.5M |
| NVO Novo Nordisk A/S | 265,016 | $10.3M |
| TNGX Tango Therapeutics, Inc. | 326,047 | $7.4M |
| ILMN Illumina, Inc. | 35,040 | $7.0M |
| ARQT Arcutis Biotherapeutics, Inc. | 242,069 | $6.6M |
| NTRA Natera, Inc. | 22,077 | $6.4M |
| SYRE Spyre Therapeutics, Inc. | 46,217 | $4.5M |
| ARGX argenx SE | 4,482 | $4.2M |
| MBX MBX Biosciences, Inc. | 70,971 | $3.8M |
| TARS Tarsus Pharmaceuticals, Inc. | 40,579 | $3.2M |
| MIRM Mirum Pharmaceuticals, Inc. | 31,536 | $3.0M |
| COR Cencora, Inc. | 7,385 | $2.5M |
| RCUS Arcus Biosciences, Inc. | 152,129 | $2.4M |
| CMPS COMPASS Pathways plc | 247,589 | $2.1M |
| DNLI Denali Therapeutics Inc. | 100,966 | $1.8M |
| BCRX BioCryst Pharmaceuticals, Inc. | 207,357 | $1.5M |
| SNDX Syndax Pharmaceuticals, Inc. | 118,422 | $1.1M |
| TECX Tectonic Therapeutic, Inc. | 45,631 | $960K |
| CAPR Capricor Therapeutics, Inc. | 122,221 | $920K |
| MLYS Mineralys Therapeutics, Inc. | 62,418 | $884K |
| HIMS Hims & Hers Health, Inc. | 49,454 | $792K |
| RZLT Rezolute, Inc. | 127,289 | $535K |
| CVRX CVRx, Inc. | 369,572 | $197K |